Drug Discovery

The successful conclusion of cancer treatment should be a moment of pure triumph, yet for many, it signals the start of a lifelong struggle with chronic, painful tissue damage—a silent epidemic born from the very therapy that saved them. While radiotherapy stands as a pillar of modern oncology, its

As a Biopharma expert at the forefront of tech and innovation, Ivan Kairatov is revolutionizing how we study the human brain. His work focuses on developing advanced, human-relevant models known as brain microphysiological systems to enhance the safety of chemical and drug testing. In our

In the persistent global battle against obesity, a new front has opened that shifts focus from the brain's appetite signals to a previously hard-to-study type of fat tissue within our own bodies. Insitro, a therapeutics company leveraging artificial intelligence for biological discovery, has

For decades, the field of oncology has striven for precision, tailoring therapies to the unique genetic fingerprint of a tumor, yet a fundamental biological variable present in every cell of a patient's body has been largely overlooked: their sex. A groundbreaking study now challenges this

In a move that sends ripples across the global pharmaceutical landscape, AstraZeneca has committed to a landmark $15 billion investment in China, a strategic initiative designed to run through 2030. The announcement, made on January 29, 2026, signals a profound deepening of the company's research,

For decades, the path from a promising antibody discovery in the lab to a life-saving therapy for patients has been fraught with uncertainty. Many drugs that show incredible potential in early tests ultimately fail in human trials, costing billions and delaying medical progress. Today we're